+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Digital Pathology Market (2021-2026) by Type, Product, Application, End-user and Geography - Competitive Analysis, Impact of COVID-19, Ansoff Analysis

  • PDF Icon

    Report

  • 189 Pages
  • March 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5359411
The Global Digital Pathology Market is estimated to be worth USD 870.6 Million in 2020 and is expected to reach USD 1,774 Million by 2025, growing at a CAGR of 15.3%.



Market Dynamics


The increasing prevalence of chronic diseases and the demand for quick and effective diagnosis are major factors propelling the growth of the digital pathology market. Furthermore, the adoption of digitalization in diagnostic to enhance lab efficacy, reducing errors, magnified imaging, and easy access of results have increased the demand for digital pathology globally. In addition, government support in the digitalization of the healthcare sector, such as the Indian government - National Digital Health Mission, has escalated the market growth. However, the high investment cost to set up digital pathology coupled with the requirement of a skilled technician is anticipated to hinder the market growth.

COVID 19 pandemic situation and growing e-labs development have created new opportunities in digital pathology. In addition, factors such as increasing R&D in the healthcare sector and expansion of digital pathology uses in teaching and training are expected to offer lucrative opportunities for market players.

Market Segmentation


The Global Digital Pathology Market is segmented based on Type, Product, Application, End-User and Geography.

  • By Type, the market is classified as human pathology and veterinary pathology. Amongst the two, the human pathology segment is estimated to hold the highest market share.
  • By Product, the market is classified as hardware and software. Amongst the two, the hardware segment is estimated to hold the highest market share
  • By Application, the market is classified mHealth, clinical trials, disease diagnosis, and others. Amongst all, the disease diagnosis segment is estimated to hold the highest market share
  • By End-users, the market is classified as Companies, Education Institutes, Hospitals, and Laboratories. Amongst all, the hospital and laboratories segment is estimated to hold the highest market share.
  • By Geography, North America is projected to lead the market.

Recent Developments


  1. Pine Labs acquired the e-commerce app FAVE for global expansion. - 13th April 2021
  2. Thermo Fisher Scientific acquired PPD, which provided clinical research and laboratory services. - 15th April 2021

Company Profiles


Some of the companies covered in this report Inspirata, Inc, Becton, Dickinson and Company, Abbott Laboratories, Koninklijke Philips N.V., MikroScan Technologies, Inc., Medtronic plc, Olympus Corporation, etc

Competitive Quadrant


The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?


The report offers a comprehensive evaluation of the Global Digital Pathology Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.

The report includes an in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of COVID-19 on the market is also featured in the report.

The report also includes the regulatory scenario of the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.

The report also contains the competitive analysis using Positioning Quadrants, the analyst's proprietary competitive positioning tool.

Report Highlights


  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Digital Pathology Market

What is the estimated value of the Global Digital Pathology Market?

The Global Digital Pathology Market was estimated to be valued at $870.6 Million in 2021.

What is the growth rate of the Global Digital Pathology Market?

The growth rate of the Global Digital Pathology Market is 15.3%, with an estimated value of $1774 Million by 2026.

What is the forecasted size of the Global Digital Pathology Market?

The Global Digital Pathology Market is estimated to be worth $1774 Million by 2026.

Who are the key companies in the Global Digital Pathology Market?

Key companies in the Global Digital Pathology Market include 3DHISTECH Ltd, Abbott Laboratories, Becto. Dickinson and Company, ContextVision, Corista LLC, Danaher Corporation, F. Hoffmann, La Roche AG and Hamamatsu Photonics K.K..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Proprietary Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Technologies Development in the Diagnostic Sector
4.1.2 Increasing Chronic Diseases and COVID Situation
4.2 Restraints
4.2.1 High Cost of Pathological Instruments
4.2.2 Lack Of Skilled Pathologists
4.3 Opportunities
4.3.1 Expansion Of Market Presence in the Education Sector and mHealth
4.3.2 Increase Investment In R&D for New Product Portfolio
4.4 Challenges
4.4.1 Stringent Government Regulations
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Digital Pathology Market, By Type
6.1 Introduction
6.2 Human Pathology
6.3 Veterinary Pathology
7 Global Digital Pathology Market, By Product
7.1 Introduction
7.2 Hardware human pathology and veterinary pathology
7.3 Software
8 Global Digital Pathology Market, By Application
8.1 Introduction
8.2 mHealth
8.3 Clinical trials
8.4 Disease Diagnosis
8.5 Others
9 Global Digital Pathology Market, By End User
9.1 Introduction
9.2 Companies
9.3 Education Institutes
9.4 Hospitals and Laboratories
10 Global Digital Pathology Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 South America
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Chile
10.3.4 Colombia
10.4 Europe
10.4.1 UK
10.4.2 France
10.4.3 Germany
10.4.4 Italy
10.4.5 Spain
10.4.6 Netherlands
10.4.7 Sweden
10.4.8 Russia
10.4.9 Rest of Europe
10.5 Asia-Pacific
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 Indonesia
10.5.5 Malaysia
10.5.6 South Korea
10.5.7 Australia
10.5.8 Sri Lanka
10.5.9 Thailand
10.5.10 Rest of APAC
10.6 Middle-East and Africa
10.6.1 Qatar
10.6.2 Saudi Arabia
10.6.3 South Africa
10.6.4 United Arab Emirates
11 Competitive Landscape
11.1 Competitive Quadrant
11.2 Market Share Analysis
11.3 Strategic Initiatives
11.3.1 M&A and Investments
11.3.2 Partnerships and Collaborations
11.3.3 Product Developments and Improvements
12 Company Profiles
12.1 3DHISTECH LTD
12.2 Abbott Laboratories
12.3 Becton, Dickinson and Company
12.4 ContextVision
12.5 Corista LLC
12.6 Danaher Corporation
12.7 F. Hoffmann-La Roche AG
12.8 Glencoe Software, Inc
12.9 Hamamatsu Photonics K.K.
12.10 Huron Technologies International Inc.
12.11 Indica Labs
12.12 Inspirata, Inc
12.13 Koninklijke Philips N.V.
12.14 Medtronic plc
12.15 MikroScan Technologies, Inc.
12.16 Olympus Corporation
12.17 OptraSCAN, Inc.
12.18 Roche Holding AG
12.19 Visiopharm A/S
12.20 XIFIN, Inc.
13 Appendix
13.1 Questionnaire

Companies Mentioned

  • 3DHISTECH Ltd
  • Abbott Laboratories
  • Becto. Dickinson and Company
  • ContextVision
  • Corista LLC
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Glencoe Softwar. Inc
  • Hamamatsu Photonics K.K.
  • Huron Technologies International Inc.
  • Indica Labs
  • Inspirat. Inc
  • Koninklijke Philips N.V.
  • Medtronic plc
  • MikroScan Technologie. Inc.
  • Olympus Corporation
  • OptraSCA. Inc.
  • Roche Holding AG
  • Visiopharm A/S
  • XIFI. Inc.